Molina Healthcare (NYSE:MOH) Stock Rating Reaffirmed by Stephens

Stephens restated their equal weight rating on shares of Molina Healthcare (NYSE:MOH) in a research note released on Thursday morning, Benzinga reports. They currently have a $390.00 price objective on the stock.

Several other equities research analysts have also recently issued reports on the stock. Bank of America cut shares of Molina Healthcare from a neutral rating to an underperform rating and set a $439.00 target price on the stock. in a research report on Thursday, March 28th. StockNews.com cut Molina Healthcare from a strong-buy rating to a buy rating in a report on Thursday, February 8th. Truist Financial upped their price target on Molina Healthcare from $435.00 to $460.00 and gave the stock a buy rating in a research note on Tuesday, February 20th. Wells Fargo & Company reduced their price objective on Molina Healthcare from $440.00 to $410.00 and set an equal weight rating on the stock in a research note on Monday, April 15th. Finally, Barclays assumed coverage on shares of Molina Healthcare in a research report on Wednesday, March 6th. They set an equal weight rating and a $437.00 target price for the company. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat, Molina Healthcare has an average rating of Hold and an average price target of $400.70.

Molina Healthcare Stock Down 2.9 %

Shares of NYSE MOH opened at $342.23 on Thursday. The firm has a market cap of $20.05 billion, a P/E ratio of 18.57, a price-to-earnings-growth ratio of 0.96 and a beta of 0.47. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.54 and a current ratio of 1.49. Molina Healthcare has a 1 year low of $266.35 and a 1 year high of $423.92. The firm’s 50 day moving average price is $390.34 and its 200 day moving average price is $372.35.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings data on Wednesday, April 24th. The company reported $5.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.46 by $0.27. The business had revenue of $9.93 billion for the quarter, compared to analysts’ expectations of $9.45 billion. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. The business’s revenue was up 21.9% on a year-over-year basis. During the same quarter last year, the firm earned $5.81 earnings per share. As a group, sell-side analysts anticipate that Molina Healthcare will post 23.62 earnings per share for the current year.

Insider Activity

In other news, CFO Mark Lowell Keim sold 15,000 shares of the company’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $386.56, for a total value of $5,798,400.00. Following the completion of the transaction, the chief financial officer now directly owns 36,531 shares in the company, valued at $14,121,423.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Molina Healthcare news, Director Richard M. Schapiro sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $401.05, for a total value of $401,050.00. Following the transaction, the director now directly owns 11,207 shares of the company’s stock, valued at approximately $4,494,567.35. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Mark Lowell Keim sold 15,000 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the sale, the chief financial officer now directly owns 36,531 shares of the company’s stock, valued at approximately $14,121,423.36. The disclosure for this sale can be found here. Insiders have sold 16,711 shares of company stock worth $6,472,517 over the last 90 days. Company insiders own 1.10% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the stock. Annis Gardner Whiting Capital Advisors LLC acquired a new stake in shares of Molina Healthcare in the 3rd quarter valued at about $30,000. McIlrath & Eck LLC bought a new position in Molina Healthcare during the 4th quarter worth approximately $34,000. VisionPoint Advisory Group LLC grew its position in shares of Molina Healthcare by 105.6% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock worth $36,000 after acquiring an additional 57 shares in the last quarter. Principal Securities Inc. bought a new stake in shares of Molina Healthcare in the 4th quarter valued at approximately $42,000. Finally, Friedenthal Financial bought a new position in Molina Healthcare during the fourth quarter worth $43,000. 98.50% of the stock is currently owned by institutional investors.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.